← Back to catalogue
Published

NR1H4

vr.tr.nr1h4 · thing-q14905041

Enable an agent to identify NR1H4, distinguish its gene and receptor forms, and interpret evidence about its expression, molecular state and experimental manipulation.

Thing Registry Physical world and living systems PHY.OBJ

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 15 findings · 25 questions

NR1H4 identity and registry boundary Resolve what the registered name denotes before attaching biological observations.

Registry referent

Establish the molecular and taxonomic scope of this entry.

Gene and receptor boundary

Require an explicit referent instead of inferring it from PHY.OBJ.

  1. Does the originating registry record denote the NR1H4 gene, its protein product or a deliberately combined molecular concept? boundary
  2. Which original identifier and organism support that interpretation? provenance

Identifier resolution

Reconcile symbols, aliases and accessions without conflating related receptors.

Alias disambiguation

Treat names such as FXR as lookup aids that require accession confirmation.

  1. Which authoritative record connects the supplied NR1H4 or FXR label to the intended species and molecular form? provenance
  2. What accession or sequence check excludes a similarly named receptor or an ortholog from another species? boundary
NR1H4 sequences and molecular forms Connect locus, transcripts, receptor isoforms and experimental constructs.

Transcript and isoform mapping

Preserve the reference chain from coding sequence to receptor product.

Reference sequence chain

Record versioned references and the evidence linking each transcript to its protein sequence.

  1. Which versioned transcript and protein accessions describe the NR1H4 form being observed? definition
  2. Does the experiment distinguish that isoform from other NR1H4 transcripts or proteins? measurement

Receptor sequence integrity

Assess changes affecting the receptor regions required by a particular experiment.

Native versus engineered receptor

Document domain coverage, substitutions, deletions and tags before interpreting function.

  1. Which DNA-binding and ligand-binding regions are present in the tested NR1H4 sequence? definition
  2. Could a truncation, tag or substitution limit what this experiment establishes about endogenous NR1H4? boundary
NR1H4 expression and cellular context Situate receptor observations in a defined tissue, cell population and cellular compartment.

Expression context

Separate endogenous expression from experimentally introduced receptor abundance.

Measured receptor abundance

Require tissue, cell identity, molecular analyte and normalization for abundance claims.

  1. In which species, tissue and cell population was NR1H4 RNA or protein measured? measurement
  2. Does the abundance reflect endogenous expression or an introduced construct, and how was it normalized? provenance

Localization context

Record where the receptor was observed under the tested conditions.

Receptor compartment evidence

Keep observed distribution separate from assumed activity.

  1. What method establishes NR1H4 compartment distribution, and at what time after treatment? measurement
  2. What additional evidence is required before interpreting the observed localization as transcriptional activation? boundary
NR1H4 ligand response and transcription Connect ligand exposure to receptor engagement and separately measured transcriptional output.

Ligand engagement

Characterize a specified ligand against a specified NR1H4 form.

Binding versus functional response

Preserve assay type, concentration and exposure when assessing ligand effects.

  1. Was direct NR1H4 binding measured, or was engagement inferred from a functional response? measurement
  2. Which ligand identity, concentration range, exposure duration and controls support the reported response? provenance

Transcriptional output

Resolve DNA-associated receptor activity from indirect downstream effects.

Target regulation evidence

Ask which target, regulatory sequence and molecular partners are supported in the tested context.

  1. Which endogenous target or reporter was measured, and what evidence distinguishes direct regulation from an indirect response? measurement
  2. Were RXR participation and relevant coregulators tested, inferred or left unresolved in this NR1H4 experiment? provenance
NR1H4 perturbation and causal interpretation Determine what receptor alterations and experimental interventions actually establish.

Variant function

Connect sequence alterations to measured molecular consequences.

Alteration and functional consequence

Distinguish predicted effects from observed changes in abundance, binding or transcription.

  1. Against which reference accession is the NR1H4 alteration described? definition
  2. Which functional consequences were directly measured, and which remain predictions? measurement

Perturbation specificity

Assess whether genetic or chemical interventions support attribution to NR1H4.

Causal attribution controls

Use specificity and rescue evidence to bound claims about receptor-dependent phenotypes.

  1. What independent perturbation, rescue or receptor-deficient control supports attribution of the observed effect to NR1H4? provenance
  2. Which additional control is needed before using this result to choose a subsequent NR1H4 experiment? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of NR1H4 this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of NR1H4 this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of NR1H4 this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of NR1H4 this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of NR1H4 this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.OBJ

What it is Filled

NR1H4 is a gene encoding the farnesoid X receptor (FXR), a bile-acid-activated nuclear receptor that regulates transcription involved in bile acid homeostasis and lipid and glucose metabolism.

In scope

  • NR1H4 identity, species and gene-to-protein relationships
  • Reference sequences, transcript variants and receptor isoforms
  • Expression and receptor localization in specified biological contexts
  • Ligand response and transcriptional activity
  • Sequence alterations and experimentally supported functional effects

Out of scope

  • Complete bile acid synthesis and transport pathways
  • Independent models of NR1H4 ligands or medicinal products
  • Whole-organ liver and intestinal physiology
  • Diagnosis and treatment of diseases associated with NR1H4
  • Other nuclear receptors and their independent molecular identities

Why it exists Filled

Enable an agent to identify NR1H4, distinguish its gene and receptor forms, and interpret evidence about its expression, molecular state and experimental manipulation.

Distinguishing features Filled

  • Resolve the symbol through a species-specific identifier: human NR1H4 maps to NCBI Gene 9971, rather than treating the name alone as sufficient identification. [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/9971/)
  • Distinguish the coding locus from its protein product: UniProt Q96RI1 identifies the human bile acid receptor protein. [UniProt](https://www.uniprot.org/uniprotkb/Q96RI1/entry)
  • Require sequence or accession evidence when separating NR1H4 from similarly named nuclear receptors.
  • Distinguish receptor identification from a functional bile acid response; a response alone does not establish which receptor mediated it.
  • Separate an endogenous NR1H4 isoform from a tagged, truncated or otherwise engineered experimental construct.

What robots and AI may and may not do Filled

Must not

  • Interpret a person's NR1H4 variant as a diagnosis of liver disease.
  • Share genetic data without consent.
  • Recommend drugs acting on this receptor to a person.
  • Present supplement claims linked to it as proven.

Only with a human decision

  • Using results in treatment decisions.
  • Research on patient samples without documented consent.

May

  • Describe NR1H4 and the bile-acid receptor it encodes, citing sources.
  • Report what a variant or expression result shows, with source and limits.

Moral aspects Filled

  • Genetic findings about liver disease affect patients and their families.
  • Health claims about bile acid signalling can mislead consumers.

Who is affected

  • Patients and families
  • Consumers
  • Researchers

Owners Filled

Steward

The person whose genome carries it; laboratories and biobanks hold records.

Master systems

  • Gene and variant databases

Links to other meta-models Filled

parent

  • Q20747295 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.nr1h4
  • Wikidata: Q14905041 (https://www.wikidata.org/wiki/Q14905041)

Direct properties required Filled

  • Molecular referent: gene locus | transcript | protein isoform | engineered construct
  • Taxonomic identity: Organism name and taxonomy identifier
  • Reference identity: Versioned gene, transcript and protein accessions; assembly for genomic coordinates
  • Sequence alteration: Reference sequence | accession-relative variant | documented construct modification
  • Expression abundance: RNA abundance in a declared normalization system; protein abundance in assay-specific units
  • Subcellular distribution: Observed compartment distribution, method and observation time
  • Ligand response: Concentration in mol/L; response and baseline; EC50 or IC50 only when fitted appropriately
  • Transcriptional effect: Target-specific expression change or reporter activity relative to a stated control

Recognition required Filled

  • Not visible; known from sequence data and receptor assays.
  • Identified by its approved gene symbol; the receptor is often called by another name.

Capabilities and actions required Filled

  • Resolve an NR1H4 label to a species, molecular form and reference accession.
  • Check whether a sequence, reagent or construct actually targets the intended NR1H4 form.
  • Compare expression or activity observations under compatible biological and assay conditions.
  • Assess whether a ligand-response experiment supports NR1H4-specific activity.
  • Identify the controls and additional evidence needed before attributing a phenotype to NR1H4.

Hazards and failure modes required Filled

  • Confusion between the gene symbol and the receptor name in reports.
  • Overinterpretation of variant associations.

Standards and interfaces required Filled

  • Human gene nomenclature, HUGO Gene Nomenclature Committee (HGNC), which approves the gene symbol.

Context of use required Filled

  • The human NR1H4 gene is encountered in studies of bile acid regulation and metabolism, particularly in liver and intestinal tissues.
  • Its sequence and transcript expression support investigation of the encoded farnesoid X receptor and its role in controlling gene transcription.

Sources Filled

  1. Wikidata item Q14905041: NR1H4 - identity and sense of the item
  2. Wikipedia: Farnesoid X receptor - general description of the item

Open questions

  • Does the originating registry identifier intend human NR1H4, another species or the receptor family across species?
  • Should the entry primarily own the gene locus or receptor protein, and does an existing Vercy model already own that referent?
  • Which transcript and protein isoforms require distinct treatment because their differences affect recognition or functional interpretation?
  • Which ligand, partner and direct-target claims have sufficient primary evidence in each relevant tissue and species?
  • Which NR1H4 alterations have reproducible functional evidence, and where do phenotype associations remain mechanistically unresolved?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q14905041/spec.json